In the realm of COVID-19 detection, a significant obstacle is being able to develop a rapid and precise identification of virus mutations that can effectively detect real-time electro-chemical processes and has enhanced overall accuracy and efficiency, creating accessibility issues for resource-limited communities.
Objectives
Design and implement a novel method that prompts DNA samples to adhere and produce a measurable signal for detecting the SARS-CoV-2 D614G mutation.
Utilize a tri-electrode system with Cyclic Voltammetry (CV) and Electrochemical Impedance Spectroscopy (EIS) to analyze signals in real-time, ensuring precise detection of viral mutations.
Integrate state-of-the-art electrochemical techniques and a multi-electrode configuration to achieve high-sensitivity readings and enable detailed monitoring of viral mutations.
Develop a simple and accessible interface, including a connected app or display, to facilitate ease of use for various users.
Our project is dedicated to the development of an advanced electrochemical biosensor with a specialized 32-electrode setup for fast, extensive and precise identification of the SARS-CoV-2 D614G mutation. This biosensor integrates cutting-edge electrochemical technology, incorporating techniques like Cyclic Voltammetry (CV) and Electrochemical Impedance Spectroscopy (EIS), to provide real-time, high-sensitivity data on viral mutations. The 32-electrode configuration enhances the biosensor's capacity, allowing for comprehensive monitoring and analysis. User-friendly interface options, such as a connected app or display, ensure accessibility for users.
Leaders: Lidia & Riam